# FDA Inspection 1019822 - Lubbock Heart Hospital LLC - March 03, 2017

Source: https://www.keypedia.com/records/fda_inspections/lubbock-heart-hospital-llc/6eebe7a3-e06a-47ed-ad0b-91419d933a36
Source feed: FDA_Inspections

> FDA Inspection 1019822 for Lubbock Heart Hospital LLC on March 03, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1019822
- Company Name: Lubbock Heart Hospital LLC
- Inspection Date: 2017-03-03
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1100261 - 2019-07-24](https://www.keypedia.com/records/fda_inspections/lubbock-heart-hospital-llc/2846bfc1-0e76-409e-92c0-c5a7eb0a0b3f)
- [FDA Inspection 925321 - 2015-04-16](https://www.keypedia.com/records/fda_inspections/lubbock-heart-hospital-llc/89edac03-a9de-4d10-b89f-54e43427ce4e)
- [FDA Inspection 815103 - 2013-01-14](https://www.keypedia.com/records/fda_inspections/lubbock-heart-hospital-llc/00e8fac0-67a7-4113-ae1e-70c9d012b0eb)

Company: https://www.keypedia.com/companies/lubbock-heart-hospital-llc/29ed4ceb-8cf1-4f92-87f9-23d992ed9b75

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d